Literature DB >> 12406073

C-reactive protein in the diagnosis of deep vein thrombosis.

Robert A Bucek1, Markus Reiter, Peter Quehenberger, Erich Minar.   

Abstract

The role of C-reactive protein (CRP) in the diagnosis of suspected deep vein thrombosis (DVT) and a possible advantage of its additional evaluation with D-dimer has not been clearly evaluated. We therefore studied plasma CRP and D-dimer levels in 233 consecutive patients with suspected DVT; the final diagnosis was based on the results of colour duplex ultrasound or venography. DVT was diagnosed in 31.3%. CRP and D-dimer correlated significantly (r = 0.64, P < 0.01); both were increased significantly in patients suffering from DVT (P < 0.001). Multivariate analysis revealed a significant influence of the presence of DVT (P < 0.001), the presence of malignancy (P < 0.001) and the presence of inflammatory diseases (P = 0.009) on plasma CRP, while there was no significant influence of the duration of symptoms (P = 0.30). The sensitivity (75% vs 93%) to specificity (69% vs 55%) relationship showed inferior results for CRP compared with D-dimer; its additional evaluation did not improve the diagnostic value of D-dimer. We conclude that CRP can provide additional information neither for the diagnostic process in patients with suspected DVT nor for the differential diagnosis of DVT and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406073     DOI: 10.1046/j.1365-2141.2002.03886.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

1.  Assessment of Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Pulmonary Embolism.

Authors:  Mehmet Baran Karataş; Göktürk İpek; Tolga Onuk; Barış Güngör; Gündüz Durmuş; Yiğit Çanga; Yasin Çakıllı; Osman Bolca
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

2.  Further evidence for sustained systemic inflammation in xenograft recipients (SIXR).

Authors:  Hayato Iwase; Burcin Ekser; Huidong Zhou; Hong Liu; Vikas Satyananda; Rishab Humar; Pooja Humar; Hidetaka Hara; Cassandra Long; Jay K Bhama; Pietro Bajona; Yi Wang; Martin Wijkstrom; David Ayares; Mohamed B Ezzelarab; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-08-21       Impact factor: 3.907

3.  Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.

Authors:  J Haltout; A Awada; M Paesmans; M Moreau; J Klastersky; G Machiels; M Ignatiadis; N Kotecki
Journal:  Support Care Cancer       Date:  2019-01-04       Impact factor: 3.603

Review 4.  Biomarkers of deep venous thrombosis.

Authors:  Huacheng Hou; Zhijuan Ge; Pu Ying; Jin Dai; Dongquan Shi; Zhihong Xu; Dongyang Chen; Qing Jiang
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

5.  Increased risk of venous thromboembolism is associated with genetic variation in heme oxygenase-1 in Blacks.

Authors:  Christopher J Bean; Sheree L Boulet; Dorothy Ellingsen; Heidi Trau; Nafisa Ghaji; W Craig Hooper; Harland Austin
Journal:  Thromb Res       Date:  2012-09-07       Impact factor: 3.944

6.  High Plasma Levels of D-Dimer Are Independently Associated with a Heightened Risk of Deep Vein Thrombosis in Patients with Intracerebral Hemorrhage.

Authors:  Xuan Cheng; Lu Zhang; Nan-Chang Xie; Yun-Qing Ma; Ya-Jun Lian
Journal:  Mol Neurobiol       Date:  2015-10-21       Impact factor: 5.590

7.  Early stroke-related deep venous thrombosis: risk factors and influence on outcome.

Authors:  Jan Bembenek; Michal Karlinski; Adam Kobayashi; Anna Czlonkowska
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

8.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Authors:  Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

9.  Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.

Authors:  Bernd Frank; Liana Ariza; Heidrun Lamparter; Vera Grossmann; Jürgen H Prochaska; Alexander Ullmann; Florentina Kindler; Gerhard Weisser; Ulrich Walter; Karl J Lackner; Christine Espinola-Klein; Thomas Münzel; Stavros V Konstantinides; Philipp S Wild
Journal:  BMJ Open       Date:  2015-07-01       Impact factor: 2.692

Review 10.  Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.

Authors:  Prakash Saha; Julia Humphries; Bijan Modarai; Katherine Mattock; Matthew Waltham; Colin E Evans; Anwar Ahmad; Ashish S Patel; Sobath Premaratne; Oliver T A Lyons; Alberto Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.